CDC Software expects 3rd-quarter earnings to surpass Wall Street’s estimates

October 30th, 2009 by admin Leave a reply »

CDC Software sees 3Q profit above expectations

ATLANTA — Business software developer CDC Software Corp. said Friday it expects its earnings to surpass Wall Street’s expectations in the third quarter.
The company forecast earnings of $5.8 million to $6.4 million for the third quarter. Excluding items, CDC expects earnings of 33 cents per share for the three [...]

Advertisement

Comments are closed.







Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research

Web Design by PlatinumShore.com & Web Hosting by TradeWebHosting.com